Animal Antibiotics and Antimicrobials Market Scope
Increasing demand for pet insurance, rising animal health spending and Growing demand for animal-derived food products will help to fuel Animal Antibiotics and Antimicrobials in the forecasted period. Animal antibiotics and antimicrobials can be used in those animals which contribute to the development of antimicrobial resistance in bacteria that may be transmitted to persons, there for it decreases the efficiency of antimicrobial drugs for handling the human disease. Growing initiatives regarding animal health and welfare are anticipated to support the whole global market for animal antimicrobials and antibiotics.
The market study is being classified by Type (Etracyclines, Penicillins, Macrolides, Aminoglycosides, Sulfonamides, Fluoroquinolones, Lincosamides, Cephalosporins and Other ), by Application (Food-producing Animals and Companion Animals) and major geographies with country level break-up.
Research Analyst at AMA predicts that United States and Europeam Players will contribute to the maximum growth of Global Animal Antibiotics and Antimicrobials market throughout the predicted period.
Zoetis, Inc. (United States), Merck & Co., Inc. (United States), Bayer AG (Germany), Eli Lilly and Company (United States), Virbac (France), Boehringer Ingelheim GmbH (Germany), Ceva Sante Animale (France), Vetoquinol S.A. (France), Sanofi (France) and Dechra Pharmaceuticals PLC (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Elanco Animal Health (United States) and Novartis International AG (Germany).
AdvanceMarketAnalytics has segmented the market of Global Animal Antibiotics and Antimicrobials market by Type, Application and Region.
On the basis of geography, the market of Animal Antibiotics and Antimicrobials has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- Rising Instances of Zoonotic Diseases will further Increase the Adoption
- Continues Increase in Animal Health Expenditure
- Increasing Demand for Food Products Derived from Animals
- Favorable Government Regulations in Preventing the Spread of Animal Diseases
- Upsurging Demand from the Untapped Emerging Economies
- Robustly Growing Population for Companion Animals may further Increase the Demand
- Growing Threat of Substitutes such as New Antibiotics as well as it can be replaced by Good Husbandry and Hygiene Practices
- Due to Increased Consumption, Growing Resistance Concerns to Antimicrobials and Antibiotics
- Complex and Lengthy Approval Process for Antimicrobials and Antibiotics
Key Target AudienceAnimal Antibiotics and Antimicrobials Manufacturers, Animal Antibiotics and Antimicrobials Distributors and Traders, Upstream and Downstream Buyers, Government Agencies, Healthcare Industry Associations, Venture Capitalist, Animal Based Industry Associations and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase